Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Leiner Health Products completes its acquisition of "substantially all" assets related to Pharmaceutical Formulations' (PFI) "solid dose pharmaceutical products business" for $23 mil. in cash, Leiner announces Sept. 26. In addition to opportunities in pain management in both OTC and supplement areas, the acquisition "allows us to enhance our contract manufacturing capabilities and expands our OTC product offering and customer base," CEO Robert Kaminski says. Leiner concurrently announces that it has amended its credit agreement, which "will enhance the company's flexibility to manage the business and support the acquisition." Leiner's plans to acquire PFI's assets were made known shortly after the Edison, N.J.-based company declared bankruptcy in July (1"The Tan Sheet" July 18, 2005, p. 4)...

You may also be interested in...

Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions

Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call

Bird Flu Creates “Opportunity” For AirShield In Immune Category, Leiner Says

The avian flu scare has created an "opportunity" for Leiner's immune system supplement AirShield, the firm said during a second-quarter 2006 earnings call

Leiner To Bolster OTC Capabilities With Purchase of PFI Assets

Private-labeler Leiner expects to significantly expand its OTC presence and market share with the proposed purchase of assets from Edison, N.J.-based Pharmaceutical Formulations, Inc. (PFI)





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts